{
  "id": "HEMORR2HAGES_Score_for_Major_Bleeding_Risk.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-07-20",
      "name": "Henrik Honkanen",
      "organisation": "Cambio CDS",
      "email": "henrik.honkanen@stud.ki.se"
    },
    "other_contributors": [
      "Daniel Keszthelyi"
    ],
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "The HEMORR2HAGES score was developed to help quantify the risk of hemorrhage in patients with atrial fibrillation on anticoagulation and to aid in the management of antithrombotic therapy.",
        "keywords": [
          "major bleeding risk",
          "anticoagulation",
          "atrial fibrillation",
          "hemorrhages risk",
          "antithrombotic therapy"
        ],
        "use": "Consider using the HEMORR2HAGES score to stratify patientsâ€™ risk for bleeding after anticoagulation for atrial fibrillation in conjunction with situation specific risks/benefits.\n\nThe final score is the total sum of the points given in some categories.\nPoints can be given for:\n1 point is given for: Hepatic or renal disease, Ethanol abuse, Malignancy, Older (age > 75), Reduced platelet count or function, Hypertension (uncontrolled), Anemia, Genetic factors (CYP 2C9 single-nucleotide polymorphisms), Excessive fall risk, and Stroke;\n2 point can be given for: Rebleeding (Prior Bleed).\n \nScore interpretation:\n- >=5 points. 12.3% risk of bleeding per 100 patient-years of warfarin. Alternative options should often be considered in patients with high-risk of major bleeding events in need of anticoagulation\n- 4 points. 10.4% risk of bleeding per 100 patient-years of warfarin.. Alternative options should often be considered in patients with high-risk of major bleeding events in need of anticoagulation\n- 3 points. 8.4% risk of bleeding per 100 patient-years of warfarin. Consider alternatives to anticoagulation unless strong indications for warfarin therapies exist\n- 2 points. 5.3% risk of bleeding per 100 patient-years of warfarin. Consider alternatives to anticoagulation unless strong indications for warfarin therapies exist\n- 1 point. 2.5% risk of bleeding per 100 patient-years of warfarin. Consider initiation of warfarin therapy if clinically indicated as risk of thrombotic events likely outweighs the risk of bleeding\n- 0 points. 1.9% risk of bleeding per 100 patient-years of warfarin. Consider initiation of warfarin therapy if clinically indicated as risk of thrombotic events likely outweighs the risk of bleeding",
        "copyright": "@Cambio CDS"
      }
    },
    "other_details": {
      "references": "1. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Radford MJ. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). American heart journal. 2006 Mar 1;151(3):713-9."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.hemorr2hages_score_for_major_bleeding_risk.v0",
        "template_id": "openEHR-EHR-OBSERVATION.hemorr2hages_score_for_major_bleeding_risk.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0005]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0006]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0009]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0011]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0012]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0014]"
          },
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0015]"
          }
        }
      },
      "gt0014": {
        "id": "gt0014",
        "model_id": "openEHR-EHR-OBSERVATION.hemorr2hages_score_for_major_bleeding_risk.v0",
        "template_id": "openEHR-EHR-OBSERVATION.hemorr2hages_score_for_major_bleeding_risk.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0017]"
          },
          "gt0016": {
            "id": "gt0016",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]"
          }
        }
      }
    },
    "rules": {
      "gt0017": {
        "id": "gt0017",
        "priority": 7,
        "when": [
          "$gt0003|Hepatic or Renal Disease|!=null",
          "$gt0004|Ethanol (Alcohol) Abuse|!=null",
          "$gt0005|Malignancy History|!=null",
          "$gt0006|Older (Age > 75)|!=null",
          "$gt0007|Reduced Platelet Count or Function|!=null",
          "$gt0008|Rebleeding Risk|!=null",
          "$gt0009|Hypertension (Uncontrolled)|!=null",
          "$gt0010|Anemia|!=null",
          "$gt0011|Genetic Factors|!=null",
          "$gt0012|Excessive Fall Risk|!=null",
          "$gt0013|Stroke History|!=null"
        ],
        "then": [
          "$gt0016|Hemorr2hages total score|.magnitude=$gt0003.value+$gt0004.value+$gt0005.value+$gt0006.value+$gt0007.value+$gt0008.value+$gt0009.value+$gt0010.value+$gt0011.value+$gt0012.value+$gt0013.value"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 6,
        "when": [
          "$gt0016|Hemorr2hages total score|==0"
        ],
        "then": [
          "$gt0015|Hemorr2hages score interpretation|=local::at0023|0 points. 1.9% risk of bleeding per 100 patient-years of warfarin. Consider initiation of warfarin therapy if clinically indicated as risk of thrombotic events likely outweighs the risk of bleeding.|"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 5,
        "when": [
          "$gt0016|Hemorr2hages total score|==1"
        ],
        "then": [
          "$gt0015|Hemorr2hages score interpretation|=local::at0022|1 point. 2.5% risk of bleeding per 100 patient-years of warfarin. Consider initiation of warfarin therapy if clinically indicated as risk of thrombotic events likely outweighs the risk of bleeding.|"
        ]
      },
      "gt0020": {
        "id": "gt0020",
        "priority": 4,
        "when": [
          "$gt0016|Hemorr2hages total score|==2"
        ],
        "then": [
          "$gt0015|Hemorr2hages score interpretation|=local::at0021|2 points. 5.3% risk of bleeding per 100 patient-years of warfarin. Consider alternatives to anticoagulation unless strong indications for warfarin therapies exist.|"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 3,
        "when": [
          "$gt0016|Hemorr2hages total score|==3"
        ],
        "then": [
          "$gt0015|Hemorr2hages score interpretation|=local::at0020|3 points. 8.4% risk of bleeding per 100 patient-years of warfarin. Consider alternatives to anticoagulation unless strong indications for warfarin therapies exist.|"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 2,
        "when": [
          "$gt0016|Hemorr2hages total score|==4"
        ],
        "then": [
          "$gt0015|Hemorr2hages score interpretation|=local::at0019|4 points. 10.4% risk of bleeding per 100 patient-years of warfarin.. Alternative options should often be considered in patients with high-risk of major bleeding events in need of anticoagulation.|"
        ]
      },
      "gt0023": {
        "id": "gt0023",
        "priority": 1,
        "when": [
          "$gt0016|Hemorr2hages total score|>=5"
        ],
        "then": [
          "$gt0015|Hemorr2hages score interpretation|=local::at0018|>=5 points. 12.3% risk of bleeding per 100 patient-years of warfarin. Alternative options should often be considered in patients with high-risk of major bleeding events in need of anticoagulation.|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "HEMORR2HAGES Score for Major Bleeding Risk",
            "description": "HEMORR2HAGES Score for Major Bleeding Risk helps to quantify the risk of hemorrhage in elderly patients with atrial fibrillation."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Hepatic or Renal Disease",
            "description": "*"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Ethanol (Alcohol) Abuse",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Malignancy History",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Older (Age > 75)",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Reduced Platelet Count or Function",
            "description": "*Includes aspirin use, any thrombocytopenia or blood dyscrasia, like hemophilia"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Rebleeding Risk",
            "description": "*History of past bleeding"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Hypertension (Uncontrolled)",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Anemia",
            "description": "*Hgb <13 g/dL for Men; Hgb <12 g/dL for Women"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Genetic Factors",
            "description": "*CYP 2C9 single-nucleotide polymorphisms"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Excessive Fall Risk",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Stroke History",
            "description": "*"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Hemorr2hages score interpretation",
            "description": "*"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Hemorr2hages total score",
            "description": "*"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Calculate Hemorr2hages total score"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Hemorr2hages 0 points score interpretation"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Hemorr2hages 1 point score interpretation"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Hemorr2hages 2 points score interpretation"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Hemorr2hages 3 points score interpretation"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Hemorr2hages 4 points score interpretation"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "Hemorr2hages 5 or more points score interpretation"
          }
        }
      }
    }
  }
}